However, as the targeted cells are mostly necrotic in nature and 7E11-C5 only recognizes the intracellular epitope of PSMA, SPECT imaging or gamma scintigraphy of prostate cancer with ProstaScint suffers low sensitivity and specificity. This evidence concerns the gene FOLH1 and prostate cancer.